Showing results (141-150 of 149) with videos related to
Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Archives of Neurology|August 1, 1985
Evaluation of zimeldine in Alzheimer's disease. Cognitive and biochemical measuresN R Cutler, J Haxby, A D Kay, et al.Journal of Clinical Psychopharmacology|December 1, 1995
A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorderJ B Adams, R E Pyke, J Costa, et al.Journal of Thrombosis and Haemostasis : JTH|June 19, 2013
Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approachJ M Kittelson, A C Spyropoulos, J L Halperin, et al.Headache|December 23, 2004
Pharmacokinetics of rizatriptan tablets during and between migraine attacksN R Cutler, S S Jhee, A K Majumdar, et al.Cephalalgia : an International Journal of Headache|October 12, 2001
Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraineB Gomez-Mancilla, N R Cutler, M T Leibowitz, et al.Alzheimer Disease and Associated Disorders|January 1, 1996
A treatment and withdrawal trial of besipirdine in Alzheimer diseaseF J Huff, P G Antuono, J E Delagandara, et al.JAMA|December 8, 1998
Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trialJ S March, J Biederman, R Wolkow, et al.Archives of Neurology|April 1, 1997
Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer diseaseN C Bodick, W W Offen, A I Levey, et al.Science (New York, N.Y.)|September 11, 1998
Distinct mechanism for antidepressant activity by blockade of central substance P receptorsM S Kramer, N Cutler, J Feighner, et al.Pageof 15